By Dr. Chinta Sidharthan A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcohol effects, a new study suggests. Glucagon-like peptide-1 ...

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

About The Article: This Viewpoint discusses the health benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs); summarizes the clinical, policy, and equity implications of GLP-1 RA ...

A drug’s watchdog has laid bare 10 deaths that are claimed to be linked to the ... They explained that a reported death doesn ...

SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...